A comprehensive mapping showed that functional CD4+ and CD8+ T cells, targeting multiple regions of SARS-CoV-2, are preserved in the resolution phase of both mild and severe COVID-19, and their magnitude correlates with the antibody response [89]. This evidence concerns the gene CD8A and COVID-19.